Nevro has received US Food and Drug Administration (FDA) approval for its Senza HFX iQ spinal cord stimulation (SCS) system to treat chronic pain.
The Senza HFX iQ SCS system has been developed for addressing the variability in pain from patient to patient and to optimise and maintain long-term pain relief, as well as improved life quality.
It includes the HFX Trial Stimulator, HFX App, HFX iQ Implantable Pulse Generator (IPG), and Charger.
